Narrow niche potential Nu-Med Plus focuses on nitric oxide delivery for specialized medical applications, signaling opportunities to target cardiology and neonatal respiratory care segments with precision delivery systems.

Regulatory readiness The company has pursued ISO 13485 certification, indicating a path toward robust quality management and regulatory compliance that can accelerate conversations with hospitals and medical device distributors.

Early-stage traction Current revenue is in the pre-revenue to low-revenue range, suggesting a thesis for strategic partnerships, pilot programs, and OEM/white-label opportunities with larger medical device manufacturers.

Global expansion potential While based in Salt Lake City, Nu-Med Plus aims to serve high-growth markets and underserved patient populations, presenting cross-border selling opportunities and collaborations with international distributors.

Technical differentiation Patented and patent-pending nitric oxide delivery technology offers a clear differentiator for devices targeting wound care, infectious diseases, COPD, malaria, and ARDS, enabling conversations around clinical efficacy and unique value propositions.